Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Greenwich LifeSciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2022
- Shares held
- 671.4K
- −121.5K (−15.3%) vs. Q3 2022
- Total value
- $10.2M
- +$2.99M (+41.4%) vs. Q3 2022
- New holders
- 3
- 5 more added
- Sold out
- 2
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $39.6M |
| Q1 2026 | 64 | $41.1M |
| Q4 2025 | 50 | $27.9M |
| Q3 2025 | 51 | $12.1M |
| Q2 2025 | 51 | $11.2M |
| Q1 2025 | 46 | $11.1M |
| Q4 2024 | 42 | $13.3M |
| Q3 2024 | 39 | $16.4M |
| Q2 2024 | 34 | $17.6M |
| Q1 2024 | 31 | $12.9M |
| Q4 2023 | 27 | $5.64M |
| Q3 2023 | 24 | $4.75M |
| Q2 2023 | 23 | $6.06M |
| Q1 2023 | 28 | $11.4M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 21 | $7.21M |
| Q2 2022 | 34 | $8.74M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 35 | $19.4M |
| Q3 2021 | 36 | $31.9M |
| Q2 2021 | 30 | $36.4M |
| Q1 2021 | 19 | $8.90M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Greenwich LifeSciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 344,524 | $5.24M | 0.00% | +880.0% | Added |
| Ameriprise Financial Inc | 65,650 | $997.0K | 0.00% | +3,949+6.4% | Added |
| BlackRock Inc. | 50,922 | $774.0K | 0.00% | +111+0.2% | Added |
| Marshall Wace, LLP | 42,503 | $646.0K | 0.00% | −34,420−44.7% | Reduced |
| Geode Capital Management, LLC | 39,933 | $606.0K | 0.00% | −2,326−5.5% | Reduced |
| Millennium Management LLC | 35,723 | $543.0K | 0.00% | −24,090−40.3% | Reduced |
| Renaissance Technologies LLC | 33,300 | $506.0K | 0.00% | −23,401−41.3% | Reduced |
| State Street Corp | 13,002 | $197.6K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 12,778 | $194.0K | 0.02% | +12,778 | New |
| 683 Capital Management, LLC | 11,700 | $177.8K | 0.02% | +11,700 | New |
| Bank of America Corp | 9,410 | $143.0K | 0.00% | −6,651−41.4% | Reduced |
| Morgan Stanley | 8,723 | $132.6K | 0.00% | −26,512−75.2% | Reduced |
| Founders Capital Management | 1,000 | $15.0K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 724 | $11.0K | 0.00% | −1,085−60.0% | Reduced |
| Royal Bank of Canada | 700 | $11.0K | 0.00% | −1−0.1% | Reduced |
| Newbridge Financial Services Group, Inc. | 500 | $7.60K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 114 | $1.73K | 0.00% | +21+22.6% | Added |
| Advisor Group Holdings, Inc. | 50 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 52 | $1.00K | 0.00% | +52 | New |
| North Star Investment Management Corp. | 51 | $775 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 24 | $365 | 0.00% | +1+4.3% | Added |
| JPMorgan Chase & Co | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −19,667−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,029−100.0% | Sold out |